Properties of antiviral agents. 2

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK.

Epidemiology and infection·2014

A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.

Health technology assessment (Winchester, England)·2011

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

Health technology assessment (Winchester, England)·2011

Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.

Health technology assessment (Winchester, England)·2010

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Thorax·2010

Influenza vaccination and asthma: current studies and recommendations.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Novel C3-Aminated Galantamine Derivatives as Selective Butyrylcholinesterase Inhibitors With Neuroprotective Effects.

ChemMedChem·2026

1,4,5,6-Tetrahydrobenzo[2,3]oxepino[4,5-d]pyrimidine derivatives as anti-neuroinflammatory agents: Design, synthesis, and preliminary biological evaluation.

Bioorganic chemistry·2026

Kaempferol attenuates microglial activation in Alzheimer's disease via inhibiting the cytosolic HK2-mediated NF-κB signaling pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Recent advances in TEAD modulators: A medicinal chemistry perspective.

European journal of medicinal chemistry·2026

AabHLH140 simultaneously enhances artemisinin and polymethoxylated flavonoid accumulation in Artemisia annua.

Plant physiology and biochemistry : PPB·2026

Flavonoids: Hemorheological effects and mechanisms of action.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Related Experiment Videos

Properties of antiviral agents. 2

Related Concept Videos

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK.

A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings.

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Influenza vaccination and asthma: current studies and recommendations.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Novel C3-Aminated Galantamine Derivatives as Selective Butyrylcholinesterase Inhibitors With Neuroprotective Effects.

1,4,5,6-Tetrahydrobenzo[2,3]oxepino[4,5-d]pyrimidine derivatives as anti-neuroinflammatory agents: Design, synthesis, and preliminary biological evaluation.

Kaempferol attenuates microglial activation in Alzheimer's disease via inhibiting the cytosolic HK2-mediated NF-κB signaling pathway.

Recent advances in TEAD modulators: A medicinal chemistry perspective.

AabHLH140 simultaneously enhances artemisinin and polymethoxylated flavonoid accumulation in Artemisia annua.

Flavonoids: Hemorheological effects and mechanisms of action.

Related Experiment Videos

Properties of antiviral agents. 2

Related Concept Videos

Related Articles